PodParley PodParley

Nirmatrelvir (Paxlovid) - summary stats and comparing between trials

An episode of the Pharmacy Microteaches podcast, hosted by Dave Abbott, titled "Nirmatrelvir (Paxlovid) - summary stats and comparing between trials" was published on January 9, 2022 and runs 7 minutes.

January 9, 2022 ·7m · Pharmacy Microteaches

0:00 / 0:00

Looking at the new Covid treatment Paxlovid (nirmatrelvir + ritonavir), how does it work and can we work out summary statistics? Then, can we compare them to the ones we worked out for molnupiravir last time? What are the problems with this approach, and why do we need to be cautious comparing outcomes between different trials? (Note: at the time of recording, there wasn't much guidance on how to pronounce nirmatrelvir, so I've gone for NIR-ma-TREL-vir rather than NIR-MAT-rel-vir or any other version. It's a best guess, so sorry if I've gone for the protease inhibitor version of CLO-pi-DOG-rel. Only time will tell)

Looking at the new Covid treatment Paxlovid (nirmatrelvir + ritonavir), how does it work and can we work out summary statistics? Then, can we compare them to the ones we worked out for molnupiravir last time? What are the problems with this approach, and why do we need to be cautious comparing outcomes between different trials? (Note: at the time of recording, there wasn't much guidance on how to pronounce nirmatrelvir, so I've gone for NIR-ma-TREL-vir rather than NIR-MAT-rel-vir or any other version. It's a best guess, so sorry if I've gone for the protease inhibitor version of CLO-pi-DOG-rel. Only time will tell)
URL copied to clipboard!